Katherine Stueland GeneDx, discusses the state of genetic testing, what its 2022 acquisition by the AI-drive genomics company SEMA4 has meant to it, and what it will take to make meaningful change to the diagnostic odyssey. Global Genes #RARECast globalgenes.org/raredaily/shor…

Thank you to our participants at the GeneDx Industry Roundtable: - Paul Kruszka, GeneDx - Jonathan Hickman, Genentech - Heather Lau, Ultragenyx - Moderated by FSU VP for Research Stacey Patterson And thank you to all the Pediatric Rare Disease Symposium sponsors: GeneDx,

Researchers from the Wellcome Sanger Institute and their collaborators at GeneDx analysed genetic data from nearly 30,000 families affected by developmental disorders biosciencetoday.co.uk/known-genes-ho…

Shares of GeneDx $WGS soaring today on a Q3 earnings beat. It was the first profitable quarter in the company's history. "Can you put patient care at the same level as profitability? We're proving day in and day out that you can," says GeneDx CEO Katherine Stueland

👶 Newborn Genome Screening 🧬 GUARDIAN study impact shared by GeneDx

Great presentation by Joe Devaney from GeneDx #ASHG2024 #ASHG24. Long-read genome sequencing are almost ready for prime time! Exciting times ahead!!

For children with epilepsy, a precise genetic diagnosis can transform treatment.

Shares of biotech company GeneDx surging on the back of its Q4 earnings beat. CEO Katherine Stueland discusses how the company is changing the landscape of genome testing: cnbc.com/video/2025/02/…

📢New today! 📰SeqFirst: Building equity access to a precise genetic diagnosis in critically ill newborns 🧑‍🤝‍🧑 mike bamshad & colleagues GeneDx Geisinger cell.com/ajhg/fulltext/…

Unlock the power of genomics! Join the GeneDx Webinar on March 27 at 12 PM ET for a CEU session on exome and genome sequencing with experts Maria J. Guillen Sacoto, MD, FACMG and Britt Johnson, PhD, FACMG. Register now: register.gotowebinar.com/register/87216….

#WorldOrphanUSA is excited to spotlight 4 more incredible Gold Sponsors confirmed for our upcoming 2025 event! 🏅 🌟 Allucent 🌟 Fortrea 🌟 GeneDx 🌟 Ergomed These organizations are key players in driving innovation, advancing treatments, and supporting the global

And ending Day 1 #PLUGSSummit2025 with a multidisciplinary Insurance Roundtable featuring Michael Astion, MD PhD Sarah Soto of GeneDx and Dr. Lon Castle of eviCore

.GeneDx CEO Katherine Stueland began her journey to the genetic-testing business as a child, when she discovered at a family reunion that multiple members of her extended family had cystic fibrosis. trib.al/0tmtXx9

"At scale, we have to do a better job at being advocates for our own healthcare." - Katherine Stueland, CEO of GeneDx, explains how AI is assisting in genomic analysis for children with autism, epilepsy, and other conditions. #FortuneAILondon

.GeneDx CEO Katherine Stueland emphasizes that while AI is revolutionizing healthcare, human effort and systemic changes are essential to significantly extend children’s lifespans. #FortuneAILondon trib.al/jHTBbDa

AI is revolutionizing health care, but three major factors will determine whether the next generation will live to see 100, according to GeneDx CEO Katherine Stueland. #FortuneAILondon | trib.al/7AggxsR

GeneDx just crowned #CerebralPalsy as a genetic testing priority - every CP dx deserves a genetic test. Listen to the episode: effieparks.com/podcast/genedx

Come along to The Festival of Genomics & Biodata, Boston to hear from Mahmoud Husseini (VP, Head of Biopharma Partnerships, GeneDx) on real world genomic data and disease prevalence. Register now: hubs.la/Q03rRd1D0 #FOGBoston

"Earlier testing gives families and clinicians more options," says GeneDx CEO Katherine Stueland on the fight against rare diseases. cnb.cx/3H1DPrS